New poll shows which childhood vaccines US parents trust
While support for childhood vaccines is high, concerns about COVID-19 vaccine safety during pregnancy reveal significant public health messaging challenges.
Scientists discover a deep brain structure crucial for holding thoughts
Reading a sentence, following a conversation, solving a problem or deciding what to do next: all of these rely on working memory.
One in three young adults turns to AI for substance use
More than 32% of participants in a Rutgers study reported using ChatGPT and similar chatbots for substance-use information.
Geriatric chronic kidney disease patients benefit from SGLT2 inhibition
New research uncovers the potential benefits and risks of sodium-glucose cotransporter 2 (SGLT2) inhibitors for adults aged 80 years or older with chronic kidney disease
Airborne ESKAPE bacteria pose severe risks to immunocompromised patients
At a clinic in South Africa, researchers have identified airborne ESKAPE bacteria which survive most antibiotic medicines. The clinic is in a densely populated inner-city
Exercise helps woman recover from partying life
Megan Hamon says her life has turned around after struggling with excessive drinking and partying.
Consultant doctors in England to strike next month
Senior doctors to stage 48-hour walkout, beginning on 25 November, in dispute over pay and pensions.
The Climate Question
Two doctors discuss the challenges for the medical sector from a warming world
Meet Anthropic’s Seven Founders as the A.I. Firm Prepares for an IPO
Former OpenAI employees started the company in 2021 after disagreements over how to safely build artificial intelligence. An I.P.O. could make them billionaires.
Anthropic S-1 Reveals Rapid Growth Ahead of Blockbuster IPO
The maker of Claude is on the verge of what could be the largest ever public listing, in a test of the A.I. industry amid
Claude helped plan risky bird flu research. What did the AI add?
Anthropic says Claude helped a scientist plan potentially risky bird flu research, a case that highlights questions about AI’s growing role in biology.
OpenAI’s discounts win Anthropic customers, The Information reports
Replit moved most of its AI spending from Anthropic to OpenAI in recent months after OpenAI offered a discount of more than 30%, The Information
Apollo’s Slok says US companies now treat AI spending as a cost, not growth
Artificial intelligence has delivered “zero financial payoff” to corporate America outside the tech sector. That is the finding of Torsten Slok, chief economist at Apollo
